Analysis Of Income And Expense [Abstract]
| Concept |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2024-01-01 to 2024-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
2023-01-01 to 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of income and expense [abstract] | ||||||||||||||||||||||||
| Revenue [abstract] | ||||||||||||||||||||||||
| Revenue | — | — | — | — | — | — | — | — | — |
89,917,000
EUR
|
— | — | — |
70,649,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Material income and expense [abstract] | ||||||||||||||||||||||||
| Impairment loss (reversal of impairment loss) on trade receivables [abstract] | ||||||||||||||||||||||||
| Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables | — | — | — | — | — | — | — | — | — |
110,000
EUR
|
— | — | — |
977,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Gains (losses) on change in fair value of derivatives [abstract] | ||||||||||||||||||||||||
| Gains (losses) on change in fair value of derivatives | — | — | — | — | — | — | — | — | — |
66,000
EUR
|
— | — | — |
194,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Expenses by nature [abstract] | ||||||||||||||||||||||||
| Raw materials and consumables used | — | — | — | — | — | — | — | — | — |
37,989,000
EUR
|
— | — | — |
36,877,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Classes of employee benefits expense [abstract] | ||||||||||||||||||||||||
| Employee benefits expense | — | — | — | — | — | — | — | — | — |
17,954,000
EUR
|
— | — | — |
18,479,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract] | ||||||||||||||||||||||||
| Depreciation and amortisation expense [abstract] | ||||||||||||||||||||||||
| Depreciation and amortisation expense | — | — | — | — | — | — | — | — | — |
10,904,000
EUR
|
— | — | — |
11,044,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Other expenses, by nature | — | — | — | — | — | — | — | — | — |
25,715,000
EUR
|
— | — | — |
10,898,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of attribution of expenses by nature to their function [abstract] | ||||||||||||||||||||||||
| Disclosure of attribution of expenses by nature to their function [line items] | ||||||||||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method [abstract] | ||||||||||||||||||||||||
| Share of profit (loss) of associates and joint ventures accounted for using equity method | — | — | — | — | — | — | — | — | — |
254,000
EUR
|
— | — | — |
217,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Comprehensive income, continuing and discontinued operations [abstract] | ||||||||||||||||||||||||
| Comprehensive income |
0
EUR
|
0
EUR
|
9,353,000
EUR
|
0
EUR
|
0
EUR
|
2,673,000
EUR
|
13,116,000
EUR
|
6,712,000
EUR
|
80,000
EUR
|
9,433,000
EUR
|
276,000
EUR
|
0
EUR
|
0
EUR
|
459,000
EUR
|
0
EUR
|
393,000
EUR
|
66,000
EUR
|
15,684,000
EUR
|
0
EUR
|
19,717,000
EUR
|
430,000
EUR
|
0
EUR
|
0
EUR
|
3,996,000
EUR
|
| Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract] | ||||||||||||||||||||||||
| Comprehensive income, attributable to owners of parent | — | — | — | — | — | — | — | — | — |
9,353,000
EUR
|
— | — | — |
393,000
EUR
|
— | — | — | — | — | — | — | — | — | — |
| Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract] | ||||||||||||||||||||||||
| Comprehensive income, attributable to non-controlling interests | — | — | — | — | — | — | — | — | — |
80,000
EUR
|
— | — | — |
66,000
EUR
|
— | — | — | — | — | — | — | — | — | — |